ILIOMAD HEALTH DATA UK LIMITEDActive

Company number 15256972Private limited companyIncorporated 2023

Key figures

£3,582-22.6%
Net assets 2025
-22.6%
Average annual change 2024–2025
02 k4 k6 k20242025

Like most small UK companies, ILIOMAD HEALTH DATA UK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k30 k20242025
Filed accounts2024–2025
20242025
Cash at bank and in hand6,39724,732
Total assets9,88228,930
Total liabilities5,25525,348
Net assets / total equity4,6273,582
Average number of employees22

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the Company is to provide data protection compliance services for Healthcare, Pharmaceutical and Healthtech companies.

As described in the company's latest filed accounts.

Summary: ILIOMAD HEALTH DATA UK LIMITED

Company

ILIOMAD HEALTH DATA UK LIMITED is a private limited company registered with Companies House under company number 15256972. It was incorporated on 2 Nov 2023. Its status is active. The registered office is in Cambridge (CB1). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £3,582, down 22.6% on the previous year. Cash at bank and in hand was £24,732. Total assets were £28,930 and total liabilities £25,348. The company had an average of 2 employees. Figures are available for 2 financial years (2024–2025).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 15 Nov 2026.